Study Finds Increased Heart Risk After Stopping GLP-1 Diabetes Medications
A recent study published in BMJ Medicine found that stopping GLP-1 medications like Ozempic and Wegovy increases the risk of major cardiovascular events, including heart attack and stroke, by up to 22% after two years off treatment. The study followed over 333,000 US veterans with type 2 diabetes for three years, comparing those on GLP-1 drugs with sulfonylurea users. Continuous GLP-1 use was linked to an 18% lower cardiovascular risk, while longer treatment interruptions raised heart risks progressively.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 43/100.
Outlets measured: timesnow, ndtv. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
ndtv broke this story on 23 Sept, 12:45 pm. Other outlets followed.
- 1